Market Closed -
Euronext Amsterdam
11:35:24 2023-05-30 am EDT
5-day change
1st Jan Change
114
EUR
+0.13%
-.--%
-.--%
Royal DSM N : BlackRock Inc. - Koninklijke DSM N.V. - Heerlen
February 02, 2023 at 03:21 pm EST
BlackRock Inc. - Koninklijke DSM N.V. - Heerlen
BlackRock Inc. - Koninklijke DSM N.V. - Heerlen
Below you will find information from the register substantial holdings and gross short positions. The information has been provided by the organisation.
Date of transaction 01 feb 2023
Person obliged to notify BlackRock Inc.
Issuing institution Koninklijke DSM N.V.
Registration Chamber of Commerce 14022069
Place of residence Heerlen
Previous result
Next result
Distribution in numbers
Type of share
Number of shares
Number of voting rights
Capital interest
Voting rights
Manner of disposal
Settlement
Type of share Contract for difference
Number of shares 104.382,00
Number of voting rights 129.339,00
Capital interest Potentieel
Voting rights Potentieel
Manner of disposal Middellijk
(BlackRock, Inc.)
Settlement In contanten
Type of share Gewoon aandeel
Number of shares 10.037.328,00
Number of voting rights 11.927.124,00
Capital interest Reëel
Voting rights Reëel
Manner of disposal Middellijk
(BlackRock, Inc.)
Settlement
Type of share Gewoon aandeel
Number of shares 247.820,00
Number of voting rights 247.820,00
Capital interest Potentieel
Voting rights Potentieel
Manner of disposal Middellijk
(BlackRock, Inc.)
Settlement Fysieke levering
Distribution in percentages
Type
Total holding
Directly real
Directly potential
Indirectly real
Indirectly potential
Type Kapitaalbelang
Total holding 4,75 %
Directly real 0,00 %
Directly potential 0,00 %
Indirectly real 4,59 %
Indirectly potential 0,16 %
Type Stemrecht
Total holding 5,62 %
Directly real 0,00 %
Directly potential 0,00 %
Indirectly real 5,45 %
Indirectly potential 0,17 %
Date last update: 02 February 2023
Disclaimer
Koninklijke DSM NV published this content on 01 February 2023 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 02 February 2023 20:20:05 UTC .
U.S. Futures Down, European Stocks Mixed
Apr. 11
DJ
DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital.
Apr. 08
CI
DSM-Firmenich AG authorizes a Buyback Plan.
Apr. 07
CI
DSM-FIRMENICH : A stronger long-term outlook
Apr. 05
Quiz sales fall, names new CEO; Byotrol eyes AIM exit
Apr. 03
AN
Quotes from Dutch companies on the worsening business climate
Mar. 12
RE
ASML's threat to leave uncovers deeper concerns in Netherlands Inc.
Mar. 12
RE
DSM-Firmenich Completes Sale of Vitamin C Plant in China
Mar. 08
MT
Jingjiang Cosfocus Health Technology Co., Ltd. acquired DSM Jiangshan Pharmaceutical Co., Ltd from DSM-Firmenich AG.
Mar. 07
CI
Philips: Chairman to seek second term
Feb. 20
CF
DSM-FIRMENICH : Some mess from the combination
Feb. 16
Global markets live: Airbus, Cisco, BAE, Salesforce, Deere...
Feb. 15
FTSE 100 Closes Up As Investors Shrug Off Recession Confirmation
Feb. 15
DJ
DSM-FIRMENICH : An even pure(er) play
Feb. 15
DSM-Firmenich Plans to Spinoff Pet Care Business
Feb. 15
CI
Dsm-firmenich Plans Pharmacokinetic Trial for New Cannabidiol Formulation With Zerion Pharma
Feb. 15
MT
Transcript : DSM-Firmenich AG, 2023 Earnings Call, Feb 15, 2024
Feb. 15
Dsm-firmenich to Carve Out Animal Nutrition Business
Feb. 15
MT
DSM Firmenich plans to separate animal nutrition and health unit
Feb. 15
RE
DSM-Firmenich AG Proposes Dividend for the Financial Year 2023
Feb. 15
CI
DSM-Firmenich AG Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 14
CI
Global markets live: TUI, Coca-Cola, Biogen, ARM Holdings, Glencore...
Feb. 13
DSM-Firmenich Amasses 98.5% Stake in DSM With Voluntary Tender Offer
Feb. 12
MT
British antitrust watchdog expands investigation into fragrance manufacturers
Jan. 17
DP
DSM-Firmenich Offers to Expedite Buy-out of Remaining DSM Shares
Jan. 08
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
More about the company
Last Close Price
106.2
EUR
Average target price
119.5
EUR
Spread / Average Target
+12.54%
Consensus
1st Jan change
Capi.
-.--% 29.69B +13.37% 884B +0.03% 239B +27.44% 164B -6.46% 127B +29.94% 79.6B -4.32% 74.67B -14.95% 51.25B -24.57% 38.6B +21.31% 33.08B
Consumer Goods Conglomerates
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1